Navarro's
Big Economic Picture
Pawn
to King Four
The
economy continues to downshift to a rate of growth below potential
output while inflation remains troublesomely high. With a stagflation
scenario now squarely in the realm of possibility and the world’s
fleet of gas guzzlers caught in a prolonged oil price shock, U.S. stock
markets continue in a clear downtrend – as does consumer confidence.
Adding to the market’s uncertainty, we’ve got a hot war in Lebanon
and a noticeable rise in terrorist activity. As Mile’s Davis once
opined: “Bitches Brew”
More
broadly, it is increasingly clear that, on the chessboard of life and
foreign policy, the Bush-Rumsfeld-Cheney team has clearly been playing
checkers. Their Iraq adventure – privately discouraged by both Colin
Powell and then-Treasury Secretary Paul O’Neill -- represents the
greatest miscalculation in American foreign policy history, far
eclipsing the Democrat’s Vietnam gambit. Consider that in Vietnam no
“dominos” ever fell. That is, no other countries in the region went
over to the Red side after the fall of Saigon, and Vietnam is now
positioned as one of the leading launching pads in Asia for
capitalist/entrepreneurial activity.
In
contrast, the Iraq adventure has already led to a significant
strengthening of the budding Iranian Shiite empire. Indeed once the U.S.
pulls the plug on Iraq, the Shiite portion of Iraq – more than half of
the country’s population -- will become nothing more than a puppet
state of Iran controlled by Iranian mullahs.
Meanwhile,
the Iranian/Shiite forces will begin to challenge all of the Sunni
states, including Egypt, Jordan, and, most ominously, Saudi Arabia. My
worst oil fear, by the way, is for the Saudi’s to succumb to a
fundamentalist revolution engineered by either Iran or Osama. If the oil
in Iran, Iraq and Saudi Arabia is controlled by Muslim fundamentalists,
oil will hit $200 a barrel or more and we will all be bicycling to work.
The sad part here is that Bush and Rumsfeld and the Dark Prince have
pushed us closer to that possibility – and please, my Republican
readers, this is a non-partisan statement, not an indictment of the
party.
This
Week's Market Movers - Ironies
Abound
Last
week, the Fed called a halt to raising interest rates, but it’s moves
were overshadowed by exogenous events, namely the latest terrorist plot
that was foiled. This week, a likely market mover will be the producer
price index on Tuesday. Any signs of inflation will be bearish.
Other
reports of interest will include housing starts and industrial
production on Wednesday, and consumer sentiment on Friday – all an all
a pretty tame week. In the dead of August and with little on the
calendar to move the markets, look for low volatility and low volume and
a meek market.
Portfolio Shorts and Longs
At
this point, I’m holding five stocks, all on the long side – and all
with the market in a clear downtrend. There’s at least a bit of method
to my madness.
Three
of the stocks are biotechs and arguably outside the business cycle’s
ups and downs. Abaxis (ABAX) makes portable blood analysis systems and
went on a tear a week or so ago. I’m scaling in, I’m slightly in the
red on this one, but not particularly worried yet. EPIX and AXCA are
Vaino biotech corner picks – and EPIX is behaving particularly well as
a long term buy and hold.
I
also opened a positing in Ansoft (ANST) based on a Market Edge
recommendation. It a design software maker used by engineers in the cell
phone, internet networking, and satellite communications spaces, to name
a few. I see this stock more as riding the wave of innovation that the
business cycle.
Lastly,
there is the Brazilian ETF EWZ. I’m down a point on a $40 stock with a
very small position but want to have my toe in these waters to see if
the Asian-Latin American economies are going to go gangbusters even if
the U.S. fades a bit. Good chance they may.
Now
let’s turn to Andrew Vaino, who revisits a stock I’ve been watching
very carefully ever since his first recommendation.

Vaino's Biotech
Corner
Making Ethanol is
Just Good Chemistry
My
advice on Diversa (DVSA) back in March was to buy and then sell in
advance of Q2 and Q3 earnings. I did this myself and was really quite
happy with the undulations of this stock. The stock, which was hovering
above $10 for a while, is back down to less than $9. I think maybe this
is a stock worth buying again.
What
I liked about Diversa back in March was their “Ultra-Thin” enzyme.
This enzyme makes it easier for industrial plants to convert the starch
in corn into simple sugars which are then fermented to ethanol. The
advantage of Diversa’s product is that it allows the manufacturing
plants to use more extreme conditions and produce ethanol more
efficiently.
An
article in last week’s Barron’s
on ethanol for fuel rekindled my interest in Diversa. In particular, the
article noted that US consumption of fuel ethanol could hit 8 billion
barrels this year, double what it was last year. In an article in the
August 9th Kearney (Nebraska)
Hub, Congressman Tom Osborne
said he “is a
bit concerned at the rate in which (ethanol) production plants are
popping up across the state.” He further went on to say, “one of my
fears is that we don’t keep up with bioscience”. I’ll drink to
that. According to the Nebraska Ethanol Energy Board, there are plans to
build 23 ethanol plants in the state. Twelve plants are currently
running. That’s a pretty significant increase in capacity.
Oil
prices dropped after events in the UK on Thursday. It’s clear to me
the expectation of decreased demand that may have caused this drop was
irrational. The decrease in supply, however, from the closure of much of
BP’s Alaskan oil field is very rational. It will be interesting to see
just how many pipes they need to replace. Bottom line, oil prices
aren’t going down anytime soon, making fuel from ethanol more
attractive.
So
here’s where it gets interesting. Since January, the price of a barrel
of ethanol has increased from $2.00 to $3.80. The price of a bushel of
corn has gone up from $1.87 in March to $2.40. A dry summer in the
Midwest is creating concern that the price of corn could increase
further. So, if ethanol plants can use corn more efficiently their
margins will increase. That’s why I think demand for Ultra-Thin will
grow stronger.
Through
their partner, Valley Research, Ultra-Thin has been tested in ten plants
to date, and more efficient throughput of corn has been seen. Another
ten of these “plant trials” are expected to be done this year.
Now,
technically DVSA isn’t a buy, but the charts show signs of
improvement. And, to be clear, Ultra-Thin so far hasn’t lived up to
Diversa’s expectations. In their March earnings call, they were
predicting $20M in sales for this year and said they thought they would
be profitable in 2007. In their earnings call on August 3rd
they were figuring sales for Ultra-Thin would probably be less than $5M
for the year. They also pushed back their expectation of profitability
until 2008.
My
take is their predictions were overly ambitious, but that they still
have a good product. Once they’re able to run some more “plant
trials” hopefully they will demonstrate Ultra-Thin’s advantages, and
sales with explode like an Appalachian still.

Matt
Davio will return after vacation
“Any
trader or investor who ignores the power of macroeconomics over the
world’s
financial markets will, sooner or later, lose more than they
should—and if they are
trading on margin, perhaps more than they
have.”
-- If It's Raining in Brazil, Buy Starbucks
|

|
Peter
Navarro is a business professor at the University of California
and the author of the best-selling investment book
If It's
Raining
in Brazil, Buy Starbucks. His latest book is
The
Well-Timed Strategy |
|

|
Matt
Davio is a managing partner at the hedge fund,
Red Rock Capital Fund.
Catch
his Daily
Blog as PeterNavarro.com
|
|

|
Andrew
Vaino is a Ph.D. chemist who spent two years at
The Scripps Research Institute in La Jolla, CA, working in the
laboratories of Nobel-Laureate Barry Sharpless and Kim Janda. He
currently teaches at The University of Maine, where his research
group is focused on exploring the interface between enzymology,
organic chemistry, and nanotechnology. |
© 2006
Peter Navarro, Matt Davio and Andrew Vaino
www.peternavarro.com
Editorial Archive
CONTACT
INFORMATION
Peter Navarro
Irvine, California USA
Email
| Website
DISCLAIMER:
This newsletter is written for educational purposes only. By no means do
any of its contents recommend, advocate or urge the buying, selling, or
holding of any financial instrument whatsoever. Trading and investing
involves high levels of risk. The authors express personal opinions and
will not assume any responsibility whatsoever for the actions of the
reader. The authors may or may not have positions in the financial
instruments discussed in this newsletter. Future results can be
dramatically different from the opinions expressed herein. Past
performance does not guarantee future performance.
Disclaimer
|